How big is the GCC In-Vitro Diagnostics Market?

The GCC In-Vitro Diagnostics Market size is expected to reach USD 2.07 billion in 2024 and grow at a CAGR of 5.10% to reach USD 2.66 billion by 2029. Read More

What is the current GCC In-Vitro Diagnostics Market size?

In 2024, the GCC In-Vitro Diagnostics Market size is expected to reach USD 2.07 billion. Read More

Who are the key players in GCC In-Vitro Diagnostics Market?

Abbott Laboratories., Danaher Corporation, F. Hoffmann-La Roche AG, Becton, Dickinson and Company and Sysmex Corporation are the major companies operating in the GCC In-Vitro Diagnostics Market. Read More

What years does this GCC In-Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the GCC In-Vitro Diagnostics Market size was estimated at USD 1.97 billion. The report covers the GCC In-Vitro Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the GCC In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

GCC In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 GCC In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. GCC In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of GCC In-Vitro Diagnostics Industry

The Gulf Cooperation Council (GCC) In-Vitro Diagnostics Market is moderately fragmented due to the presence of many companies operating regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some of the major players in the market are Abbott Laboratories, Danaher Corporation, BioMerieux SA, Sysmex Corporation, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Siemens Healthineers (Siemens Healthcare GmbH), Qiagen NV, Thermo Fischer Scientific Inc., Grifols SA among others.